Recurrent hemolytic uremic syndrome in an adult renal allograft recipient

Current concepts and management

Anupam Agarwal, Michael Mauer, Arthur J Matas, Karl A. Nath

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Acute renal insufficiency in the setting of hemolysis and thrombocytopenia, a triad that constitutes adult or pediatric hemolytic uremic syndrome, can be associated with or triggered by diverse conditions such as verocytotoxin-producing Escherichia coli, viral infections, pregnancy, malignant hypertension, scleroderma, renal radiation, allograft rejection, lupus erythematosus, and assorted medications such as mitomycin C, cyclosporine, and oral contraceptives. Recurrent and de novo hemolytic uremic syndrome occur after renal transplantation. Relapses are also common and probably reflect incomplete resolution of the initial episode. The major differential diagnoses of hemolytic uremic syndrome in the renal allograft include acute vascular rejection, cyclosporine, FK506 or antilymphocyte antibody nephrotoxicity, and malignant hypertension, all of which may display overlapping clinical and histologic features with primary hemolytic uremic syndrome; in such instances, the exact diagnosis may be quite difficult. It is possible that the risk of recurrence may be reduced by proper timing of transplantation and suitable choice of immunosuppressive agents. Intensive plasmapheresis in conjunction with fresh frozen plasma and supportive management of renal failure may lessen mortality and morbidity even in recurrent hemolytic uremic syndrome after transplantation.

Original languageEnglish (US)
Pages (from-to)1160-1169
Number of pages10
JournalJournal of the American Society of Nephrology
Volume6
Issue number4
StatePublished - Oct 1 1995

Fingerprint

Hemolytic-Uremic Syndrome
Allografts
Kidney
Malignant Hypertension
Cyclosporine
Transplantation
Recurrence
Escherichia coli Infections
Antilymphocyte Serum
Plasmapheresis
Mitomycin
Tacrolimus
Virus Diseases
Immunosuppressive Agents
Oral Contraceptives
Hemolysis
Acute Kidney Injury
Thrombocytopenia
Kidney Transplantation
Renal Insufficiency

Keywords

  • Acute rejection
  • Cyclosporine
  • Plasmapheresis
  • Renal transplantation

Cite this

Recurrent hemolytic uremic syndrome in an adult renal allograft recipient : Current concepts and management. / Agarwal, Anupam; Mauer, Michael; Matas, Arthur J; Nath, Karl A.

In: Journal of the American Society of Nephrology, Vol. 6, No. 4, 01.10.1995, p. 1160-1169.

Research output: Contribution to journalArticle

@article{3c8a57003977435bba987767aa8cc627,
title = "Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: Current concepts and management",
abstract = "Acute renal insufficiency in the setting of hemolysis and thrombocytopenia, a triad that constitutes adult or pediatric hemolytic uremic syndrome, can be associated with or triggered by diverse conditions such as verocytotoxin-producing Escherichia coli, viral infections, pregnancy, malignant hypertension, scleroderma, renal radiation, allograft rejection, lupus erythematosus, and assorted medications such as mitomycin C, cyclosporine, and oral contraceptives. Recurrent and de novo hemolytic uremic syndrome occur after renal transplantation. Relapses are also common and probably reflect incomplete resolution of the initial episode. The major differential diagnoses of hemolytic uremic syndrome in the renal allograft include acute vascular rejection, cyclosporine, FK506 or antilymphocyte antibody nephrotoxicity, and malignant hypertension, all of which may display overlapping clinical and histologic features with primary hemolytic uremic syndrome; in such instances, the exact diagnosis may be quite difficult. It is possible that the risk of recurrence may be reduced by proper timing of transplantation and suitable choice of immunosuppressive agents. Intensive plasmapheresis in conjunction with fresh frozen plasma and supportive management of renal failure may lessen mortality and morbidity even in recurrent hemolytic uremic syndrome after transplantation.",
keywords = "Acute rejection, Cyclosporine, Plasmapheresis, Renal transplantation",
author = "Anupam Agarwal and Michael Mauer and Matas, {Arthur J} and Nath, {Karl A.}",
year = "1995",
month = "10",
day = "1",
language = "English (US)",
volume = "6",
pages = "1160--1169",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "4",

}

TY - JOUR

T1 - Recurrent hemolytic uremic syndrome in an adult renal allograft recipient

T2 - Current concepts and management

AU - Agarwal, Anupam

AU - Mauer, Michael

AU - Matas, Arthur J

AU - Nath, Karl A.

PY - 1995/10/1

Y1 - 1995/10/1

N2 - Acute renal insufficiency in the setting of hemolysis and thrombocytopenia, a triad that constitutes adult or pediatric hemolytic uremic syndrome, can be associated with or triggered by diverse conditions such as verocytotoxin-producing Escherichia coli, viral infections, pregnancy, malignant hypertension, scleroderma, renal radiation, allograft rejection, lupus erythematosus, and assorted medications such as mitomycin C, cyclosporine, and oral contraceptives. Recurrent and de novo hemolytic uremic syndrome occur after renal transplantation. Relapses are also common and probably reflect incomplete resolution of the initial episode. The major differential diagnoses of hemolytic uremic syndrome in the renal allograft include acute vascular rejection, cyclosporine, FK506 or antilymphocyte antibody nephrotoxicity, and malignant hypertension, all of which may display overlapping clinical and histologic features with primary hemolytic uremic syndrome; in such instances, the exact diagnosis may be quite difficult. It is possible that the risk of recurrence may be reduced by proper timing of transplantation and suitable choice of immunosuppressive agents. Intensive plasmapheresis in conjunction with fresh frozen plasma and supportive management of renal failure may lessen mortality and morbidity even in recurrent hemolytic uremic syndrome after transplantation.

AB - Acute renal insufficiency in the setting of hemolysis and thrombocytopenia, a triad that constitutes adult or pediatric hemolytic uremic syndrome, can be associated with or triggered by diverse conditions such as verocytotoxin-producing Escherichia coli, viral infections, pregnancy, malignant hypertension, scleroderma, renal radiation, allograft rejection, lupus erythematosus, and assorted medications such as mitomycin C, cyclosporine, and oral contraceptives. Recurrent and de novo hemolytic uremic syndrome occur after renal transplantation. Relapses are also common and probably reflect incomplete resolution of the initial episode. The major differential diagnoses of hemolytic uremic syndrome in the renal allograft include acute vascular rejection, cyclosporine, FK506 or antilymphocyte antibody nephrotoxicity, and malignant hypertension, all of which may display overlapping clinical and histologic features with primary hemolytic uremic syndrome; in such instances, the exact diagnosis may be quite difficult. It is possible that the risk of recurrence may be reduced by proper timing of transplantation and suitable choice of immunosuppressive agents. Intensive plasmapheresis in conjunction with fresh frozen plasma and supportive management of renal failure may lessen mortality and morbidity even in recurrent hemolytic uremic syndrome after transplantation.

KW - Acute rejection

KW - Cyclosporine

KW - Plasmapheresis

KW - Renal transplantation

UR - http://www.scopus.com/inward/record.url?scp=0028869010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028869010&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 1160

EP - 1169

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 4

ER -